Titre :
  • Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Auteur : Catimel, G ; Verweij, Jaap ; Mattijssen, V ; Hanauske, Axel-R ; Piccart-Gebhart, Martine ; Wanders, Jantien ; Franklin, H ; Le Bail, N ; Clavel, Michel ; Kaye, S B
Informations sur la publication : Annals of oncology, 5, 6, (page 533-537)
Statut de publication : Publié, 1994-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Alopecia -- chemically induced
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Agents, Phytogenic -- adverse effects
Antineoplastic Agents, Phytogenic -- therapeutic use
Asthenia -- chemically induced
Carcinoma, Squamous Cell -- drug therapy
Drug Administration Schedule
Europe
Female
Head and Neck Neoplasms -- drug therapy
Humans
Male
Middle Aged
Neutropenia -- chemically induced
Paclitaxel -- administration & dosage
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Paclitaxel -- therapeutic use
Remission Induction
Taxoids
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/7918125